Phosphorylation puts the pRb tumor suppressor into shape

Genes and Development

Volumn 26, Issue 11, 2012, Pages 1128-1130

  Heilmann, Andreas M F ^a   Dyson, Nicholas J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle regulation; Cyclin dependent kinase; Multisite phosphorylation; Retinoblastoma protein; Small angle X ray scattering (SAXS); X ray crystal structure

Indexed keywords

PHOSPHOTHREONINE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; COMPETITIVE INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RADIATION SCATTERING;

CELL CYCLE; RETINOBLASTOMA PROTEIN;

EID: 84861777027     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.195552.112     Document Type: Article

References (22)

1. Brown VD, Phillips RA, Gallie BL. 1999. Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol 19: 3246-3256.
2. Buchkovich K, Duffy LA, Harlow E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105.
3. Burke JR, Deshong AJ, Pelton JG, Rubin SM. 2010. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285: 16286-16293.
4. Burke JR, Hura GL, Rubin SM. 2012. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev (this issue). doi: 10.1101/gad.189837. 112.
5. Chen PL, Scully P, Shew JY, Wang JY, Lee WH. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198.
6. Chinnam M, Goodrich DW. 2011. RB1, development, and cancer. Curr Top Dev Biol 94: 129-169.
7. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085-1095.
8. Dick FA. 2007. Structure-function analysis of the retinoblastoma tumor suppressor protein-is the whole a sum of its parts?. Cell Div 2: 26. doi: 10.1186/1747-1028-2-26.
9. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646.
10. Goodrich DW. 2006. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 25: 5233-5243.
11. Gorges LL, Lents NH, Baldassare JJ. 2008. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Am J Physiol Cell Physiol 295: C1151-C1160. doi: 10.1152/ajpcell.00300.2008.
12. Hassler M, Singh S, Yue WW, Luczynski M, Lakbir R, Sanchez-Sanchez F, Bader T, Pearl LH, Mittnacht S. 2007. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell 28: 371-385.
13. Knudsen ES, Wang JY. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 271: 8313-8320.
14. Knudsen ES, Wang JY. 1997. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 17: 5771-5783.
15. Lee JO, Russo AA, Pavletich NP. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391: 859-865.
16. Lee C, Chang JH, Lee HS, Cho Y. 2002. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev 16: 3199-3212.
17. Lents NH, Gorges LL, Baldassare JJ. 2006. Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB). Cell Cycle 5: 1699-1707.
18. Morris EJ, Dyson NJ. 2001. Retinoblastoma protein partners. Adv Cancer Res 82: 1-54.
19. Rubin SM, Gall AL, Zheng N, Pavletich NP. 2005. Structure of the Rb C-terminal domain bound to E2F1-DP1: A mechanism for phosphorylation-induced E2F release. Cell 123: 1093-1106.
20. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
21. Xiao B, Spencer J, Clements A, Ali-Khan N, Mittnacht S, Broceno C, Burghammer M, Perrakis A, Marmorstein R, Gamblin SJ. 2003. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci 100: 2363-2368.
22. Zarkowska T, Mittnacht S. 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746.